{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:37:02Z","timestamp":1793137022664,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Otolaryngology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.amjoto.2024.104597","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T02:29:44Z","timestamp":1736130584000},"page":"104597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a multicentric Sicilian experience"],"prefix":"10.1016","volume":"46","author":[{"given":"Cosimo","family":"Galletti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Sireci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Stilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonietta","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliano","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Manzella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Portelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Guglielmo","family":"Zappal\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariut","family":"Diana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Frangipane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Immordino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Lorusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Dispensa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ciodaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Freni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Galletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Gallina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignazio","family":"La Mantia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Galletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjoto.2024.104597_bb0005","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s40265-020-01298-9","article-title":"Dupilumab: a review in chronic rhinosinusitis with nasal polyps","volume":"80","author":"Hoy","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.amjoto.2024.104597_bb0010","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3390\/jpm12091526","article-title":"Effectiveness of Dupilumab in the treatment of patients with uncontrolled severe CRSwNP: a \u201creal-life\u201d observational study in Na\u00efve and post-surgical patients","volume":"12","author":"Ottaviano","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.amjoto.2024.104597_bb0015","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3390\/jcm11040926","article-title":"Efficacy of biologics on refractory eosinophilic otitis media associated with bronchial asthma or severe uncontrolled CRSwNP","volume":"11","author":"De Corso","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.amjoto.2024.104597_bb0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2147\/TCRM.S210648","article-title":"Therapeutic potential of Dupilumab in the treatment of chronic rhinosinusitis with nasal polyps: evidence to date","volume":"16","author":"Kim","year":"2020","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.amjoto.2024.104597_bb0025","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1111\/all.14809","article-title":"Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: a systematic review for the EAACI guidelines","volume":"76","author":"Agache","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.amjoto.2024.104597_bb0030","first-page":"1","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","author":"Fokkens","year":"2020","journal-title":"Rhinol J"},{"issue":"12","key":"10.1016\/j.amjoto.2024.104597_bb0035","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1111\/all.13875","article-title":"EUFOREA consensus on biologics for CRSwNP with or without asthma","volume":"74","author":"Fokkens","year":"2019","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.amjoto.2024.104597_bb0040","first-page":"331","article-title":"Patient advisory board for chronic rhinosinusitis - a EUFOREA initiative","volume":"57","author":"Pugin","year":"2019","journal-title":"Rhinology"},{"key":"10.1016\/j.amjoto.2024.104597_bb0045","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/000164800760370873","article-title":"Evaluation of methods for endoscopic staging of nasal polyposis","volume":"120","author":"Johansson","year":"2000","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.amjoto.2024.104597_bb0050","first-page":"183","article-title":"Staging in rhinosinusitis","volume":"31","author":"Lund","year":"1993","journal-title":"Rhinology"},{"key":"10.1016\/j.amjoto.2024.104597_bb0055","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.otohns.2007.02.004","article-title":"The Lund-Mackay staging system for chronic rhinosinusitis: how is it used, and what does it predict?","volume":"137","author":"Hopkins","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.amjoto.2024.104597_bb0060","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3390\/jpm14040414","article-title":"The morphology of nasal polyps in different age groups: histopathological features","volume":"14","author":"Fiorentino","year":"2024","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.amjoto.2024.104597_bb0065","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaip.2016.05.004","article-title":"Phenotypes and emerging Endotypes of chronic rhinosinusitis","volume":"4","author":"Bachert","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.amjoto.2024.104597_bb0070","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomized, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.amjoto.2024.104597_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.572749","article-title":"Interleukin-13 alters tight junction proteins expression thereby compromising barrier function and dampens rhinovirus induced immune responses in nasal epithelium","volume":"8","author":"Huang","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.amjoto.2024.104597_bb0080","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/all.15074","article-title":"Endotypes of chronic rhinosinusitis: relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches","volume":"77","author":"Kato","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.amjoto.2024.104597_bb0085","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/MOO.0000000000000503","article-title":"Endotypes of chronic rhinosinusitis","volume":"27","author":"Yip","year":"2019","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"4","key":"10.1016\/j.amjoto.2024.104597_bb0090","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jaci.2017.05.044","article-title":"Reduced need for surgery in severe nasal polyposis with mepolizumab: randomized trial","volume":"140","author":"Bachert","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.amjoto.2024.104597_bb0095","first-page":"1141","article-title":"Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomized, double-blind, placebo-controlled, phase 3 trial. Lancet","volume":"9","author":"Han","year":"2021","journal-title":"Respir Med"},{"key":"10.1016\/j.amjoto.2024.104597_bb0100","series-title":"Global strategy for asthma management and prevention","article-title":"Global initiative for asthma","author":"Reddel","year":"2022"},{"key":"10.1016\/j.amjoto.2024.104597_bb0105","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaci.2019.06.049","article-title":"Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence","volume":"145","author":"Bousquet","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.amjoto.2024.104597_bb0110","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3390\/ph16040630","article-title":"Effectiveness and safety profile of Dupilumab in chronic rhinosinusitis with nasal polyps: real-life data in tertiary care","volume":"16","author":"Galletti","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.amjoto.2024.104597_bb0115","article-title":"Dupilumab in chronic rhinosinusitis with nasal polyps: real life data in a multicentric Sicilian experience","volume":"45","author":"Galletti","year":"2023","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.amjoto.2024.104597_bb0120","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation, and treatment of severe asthma","volume":"43","author":"Chung","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjoto.2024.104597_bb0125","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3390\/biomedicines11020485","article-title":"Real-life effectiveness of Mepolizumab in refractory chronic rhinosinusitis with nasal polyps","volume":"11","author":"Dom\u00ednguez-Sosa","year":"2023","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.amjoto.2024.104597_bb0130","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11882-021-01013-y","article-title":"Biologic therapies for allergic rhinitis and nasal polyposis","volume":"21","author":"Geng","year":"2021","journal-title":"Curr Allergy Asthma Rep"},{"issue":"8","key":"10.1016\/j.amjoto.2024.104597_bb0135","doi-asserted-by":"crossref","first-page":"100676","DOI":"10.1016\/j.waojou.2022.100676","article-title":"Current and emerging biologic therapies targeting eosinophilic disorders","volume":"15","author":"Pitlick","year":"2022","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.amjoto.2024.104597_bb0140","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3390\/jpm12081304","article-title":"Mepolizumab improves outcomes of chronic rhinosinusitis with nasal polyps in severe asthmatic patients: a multicentric real-life study","volume":"12","author":"Gallo","year":"2022","journal-title":"J. Pers. Med."},{"issue":"4","key":"10.1016\/j.amjoto.2024.104597_bb0145","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jaci.2017.05.044","article-title":"Reduced need for surgery in severe nasal polyposis with mepolizumab: randomized trial","volume":"140","author":"Bachert","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.amjoto.2024.104597_bb0150","doi-asserted-by":"crossref","DOI":"10.1177\/17534666211009398","article-title":"Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study","volume":"15","author":"Detoraki","year":"2021","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.amjoto.2024.104597_bb0155","author":"European Medicines Agency"},{"issue":"4","key":"10.1016\/j.amjoto.2024.104597_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjoto.2024.104329","article-title":"Effectiveness and safety profile of mepolizumab in chronic rhinosinusitis with nasal polyps: real life data in a tertiary care","volume":"45","author":"Galletti","year":"2024","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.amjoto.2024.104597_bb0165","author":"GlaxoSmithKline"},{"key":"10.1016\/j.amjoto.2024.104597_bb0170","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1016\/j.jaip.2021.07.050","article-title":"Safety and efficacy of Mepolizumab in hypereosinophilic syndrome: an open-label extension study","volume":"9","author":"Gleich","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.amjoto.2024.104597_bb0175","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S2213-2600(21)00097-7","article-title":"Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Ardusso","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.amjoto.2024.104597_bb0180","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jaci.2006.09.007","article-title":"Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis","volume":"118","author":"Stein","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.amjoto.2024.104597_bb0185","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","volume":"376","author":"Wechsler","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjoto.2024.104597_bb0190","article-title":"Mepolizumab in the treatment of severe asthma with nasal polyposis: real-life study","volume":"58","author":"da Costa Martins","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjoto.2024.104597_bb0195","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1159\/000514262","article-title":"Real-life experience of monoclonal antibody treatments in chronic rhinosinusitis with nasal polyposis","volume":"182","author":"Meier","year":"2021","journal-title":"Int Arch Allergy Immunol"},{"issue":"10","key":"10.1016\/j.amjoto.2024.104597_bb0200","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1016\/j.jaip.2022.05.019","article-title":"Effect of dupilumab on blood eosinophil counts in patients with asthma, chronic rhinosinusitis with nasal polyps, atopic dermatitis, or eosinophilic esophagitis","volume":"10","author":"Wechsler","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.amjoto.2024.104597_bb0205","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev-pathol-052016-100401","article-title":"Immunopathogenesis of chronic rhinosinusitis and nasal polyposis","volume":"12","author":"Schleimer","year":"2017","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"10.1016\/j.amjoto.2024.104597_bb0210","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/alr.23234","article-title":"Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: a systematic review of the current knowledge towards an attempt to compare agents\u2019 efficacy","volume":"14","author":"Papacharalampous","year":"2024","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.amjoto.2024.104597_bb0215","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.jaci.2018.09.033","article-title":"Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma","volume":"143","author":"Khatri","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.amjoto.2024.104597_bb0220","first-page":"1156","article-title":"Safety profile of Dupilumab approved for chronic rhinosinusitis with nasal polyposis: analysis from the European spontaneous adverse event reporting system","volume":"45","author":"Barbieri","year":"2022","journal-title":"Drug Saf"},{"key":"10.1016\/j.amjoto.2024.104597_bb0225","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/14740338.2017.1286327","article-title":"The safety of mepolizumab for the treatment of asthma","volume":"16","author":"Leung","year":"2017","journal-title":"Expert Opin Drug Saf"}],"container-title":["American Journal of Otolaryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196070924003831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196070924003831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T20:21:04Z","timestamp":1741033264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196070924003831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0196070924003831"],"URL":"https:\/\/doi.org\/10.1016\/j.amjoto.2024.104597","relation":{},"ISSN":["0196-0709"],"issn-type":[{"value":"0196-0709","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a multicentric Sicilian experience","name":"articletitle","label":"Article Title"},{"value":"American Journal of Otolaryngology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjoto.2024.104597","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104597"}}